Angioplasty with the scepter C dual lumen balloon catheter and postprocedural result evaluation in patients with subarachnoid hemorrhage related vasospasms.
Angioplasty
Balloon-catheter
Scepter C balloon catheter
Subarachnoid hemorrhage
Vasospasms
iFlow tool
Journal
BMC neurology
ISSN: 1471-2377
Titre abrégé: BMC Neurol
Pays: England
ID NLM: 100968555
Informations de publication
Date de publication:
29 Jun 2020
29 Jun 2020
Historique:
received:
15
03
2019
accepted:
17
05
2020
entrez:
1
7
2020
pubmed:
1
7
2020
medline:
24
10
2020
Statut:
epublish
Résumé
Delayed cerebral ischemia is one of the leading causes of death and disability in patients with subarachnoid hemorrhage (SAH). Transluminal balloon angioplasty (TBA) is a therapeutic option for vasospasms affecting proximal intracranial arteries. Aim of this study was to report our experience using the Scepter C balloon catheter in the treatment of cerebral vasospasms due to SAH and evaluate the postprocedural result with the iFlow tool. We reviewed cases of patients treated at our hospital from 2014 to 2018. Patients were screened with transcranial doppler sonography (TCD) and multimodal computed tomography. In case of significant vasospasms, patients were transferred to the angiography suite and treated. We used the iFlow tool to quantify and evaluate the angiographic results by measuring and comparing peak density values on angiograms before and after the mechanical dilation. The use of the Scepter C balloon catheter was feasible in all cases. Vasospasms of the anterior cerebral artery were treated in ten cases. We didn't observe complications or vasospasm recurrences of the treated arteries. The temporal difference between distal vessels and the proximal reference vessel was significantly reduced from a mean of 53%, prior to dilatation, to 26% after the treatment. The difference between pre-dilatation and post-dilatation values was statistically significant for the anterior circulation at the proximal as well as at the distal vessels. We successfully treated endovascularly patients suffering from cerebral vasospasms refractory to medical treatment using the Scepter C balloon catheter. We didn't observe any complications. The therapeutic effect could be easily and reliably assessed with the iFlow tool.
Sections du résumé
BACKGROUND
BACKGROUND
Delayed cerebral ischemia is one of the leading causes of death and disability in patients with subarachnoid hemorrhage (SAH). Transluminal balloon angioplasty (TBA) is a therapeutic option for vasospasms affecting proximal intracranial arteries.
METHODS
METHODS
Aim of this study was to report our experience using the Scepter C balloon catheter in the treatment of cerebral vasospasms due to SAH and evaluate the postprocedural result with the iFlow tool. We reviewed cases of patients treated at our hospital from 2014 to 2018. Patients were screened with transcranial doppler sonography (TCD) and multimodal computed tomography. In case of significant vasospasms, patients were transferred to the angiography suite and treated. We used the iFlow tool to quantify and evaluate the angiographic results by measuring and comparing peak density values on angiograms before and after the mechanical dilation.
RESULTS
RESULTS
The use of the Scepter C balloon catheter was feasible in all cases. Vasospasms of the anterior cerebral artery were treated in ten cases. We didn't observe complications or vasospasm recurrences of the treated arteries. The temporal difference between distal vessels and the proximal reference vessel was significantly reduced from a mean of 53%, prior to dilatation, to 26% after the treatment. The difference between pre-dilatation and post-dilatation values was statistically significant for the anterior circulation at the proximal as well as at the distal vessels.
CONCLUSIONS
CONCLUSIONS
We successfully treated endovascularly patients suffering from cerebral vasospasms refractory to medical treatment using the Scepter C balloon catheter. We didn't observe any complications. The therapeutic effect could be easily and reliably assessed with the iFlow tool.
Identifiants
pubmed: 32600433
doi: 10.1186/s12883-020-01792-3
pii: 10.1186/s12883-020-01792-3
pmc: PMC7322884
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
260Références
J Clin Neurosci. 1994 Jan;1(1):19-26
pubmed: 18638721
Can J Neurol Sci. 2016 Jan;43(1):15-32
pubmed: 26332908
J Neurointerv Surg. 2014 Mar;6(2):125-8
pubmed: 23371937
J Neurosurg. 1988 Apr;68(4):505-17
pubmed: 3280746
Neurology. 2010 May 11;74(19):1494-501
pubmed: 20375310
Neurosurgery. 1988 Mar;22(3):484-91
pubmed: 3283595
Stroke. 1999 Jul;30(7):1402-8
pubmed: 10390314
J Neurosurg. 1990 Jul;73(1):18-36
pubmed: 2191090
Stroke. 1995 Sep;26(9):1553-7
pubmed: 7660397
N Engl J Med. 1983 Mar 17;308(11):619-24
pubmed: 6338383
Acta Neurochir (Wien). 1986;82(3-4):110-4
pubmed: 3538789
J Neurosurg. 1988 Nov;69(5):683-6
pubmed: 3054010
Neurosurg Clin N Am. 1994 Jul;5(3):437-47
pubmed: 8086797
Neurosurgery. 2008 Mar;62(3):610-7; discussion 610-7
pubmed: 18301345
Can J Surg. 1994 Oct;37(5):391-6
pubmed: 7922900
Neurosurgery. 2000 Feb;46(2):462-9; discussion 469-70
pubmed: 10690736
BMJ. 1989 Mar 11;298(6674):636-42
pubmed: 2496789
J Neurosurg. 1997 Dec;87(6):830-5
pubmed: 9384391
Neurosurgery. 1998 May;42(5):979-86; discussion 986-7
pubmed: 9588541
World Neurosurg. 2015 Jun;83(6):1120-1126.e1
pubmed: 25681601
Stroke. 2012 Jun;43(6):1711-37
pubmed: 22556195
Stroke. 1994 Jul;25(7):1342-7
pubmed: 8023347
Cardiovasc Intervent Radiol. 2016 Jun;39(6):824-30
pubmed: 26817759
Neurosurgery. 2006 Nov;59(5 Suppl 3):S139-47; discussion S3-13
pubmed: 17053596
J Neurosurg. 1996 Mar;84(3):405-14
pubmed: 8609551
Neurosurgery. 2011 Jul;69(1):95-101; discussion 102
pubmed: 21368694
Neurosurg Rev. 1995;18(1):7-13
pubmed: 7566534
Neurosurg Clin N Am. 2005 Jul;16(3):501-16, vi
pubmed: 15990041
J Neurosurg. 2007 Dec;107(6):1101-12
pubmed: 18077946
Neurocrit Care. 2014 Jun;20(3):399-405
pubmed: 23463421